Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives
Monoclonal antibodies have been the most successful therapeutics ever brought to cancer treatment by immune technologies. The use of monoclonal antibodies in B-cell Non-Hodgkin's lymphomas (NHL) represents the greatest example of these advances, as the introduction of the anti-CD20 antibody rit...
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Wiley
2010-01-01
|
| Seri Bilgileri: | Clinical and Developmental Immunology |
| Online Erişim: | http://dx.doi.org/10.1155/2010/428253 |